Tatiana S Karpova

Dr. Tatiana S Karpova


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Cell
Verified
Journal Article
Closed access
ESErin E. Swinstead
Erin E. Swinstead
TMTina B. Miranda
Tina B. Miranda
VPVille Paakinaho
Ville Paakinaho
SBSongjoon Baek
Songjoon Baek
IGIdo Goldstein
Ido Goldstein
GHGordon L. Hager
Gordon L. Hager

1 November 1999 in Methods
Verified
Journal Article
Closed access
JMJames G. McNally
James G. McNally
TKTatiana S Karpova
Tatiana S Karpova
JCJohn Cooper
John Cooper
JCJosé Angel Conchello
José Angel Conchello

1 April 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
XQXiaolan Qian
Xiaolan Qian
TKTatiana S Karpova
Tatiana S Karpova
ASAllan M Sheppard
Allan M Sheppard
JMJames McNally
James McNally
DLDouglas R Lowy
Douglas R Lowy
E‐cadherin is an essential adhesion protein as well as a tumor suppressor that is silenced in many cancers. Its adhesion‐dependent regulation of signaling has not been elucidated. We report that E‐cadherin can negatively regulate, in an adhesion‐dependent manner, the ligand‐dependent activation of divergent classes of receptor tyrosine kinases (RTKs), by inhibiting their ligand‐dependent activation in association with decreases in receptor mobility and in ligand‐binding affinity. E‐cadherin did not regulate a constitutively active mutant RTK (Neu*) or the ligand‐dependent activation of LPA receptors or muscarinic receptors, which are two classes of G protein‐coupled receptors. EGFR regulation by E‐cadherin was associated with complex formation between EGFR and E‐cadherin that depended on the extracellular domain of E‐cadherin but was independent of β‐catenin binding or p120‐catenin binding. Transfection of E‐cadherin conferred negative RTK regulation to human melanoma and breast cancer lines with downregulated endogenous E‐cadherin. Abrogation of E‐cadherin regulation may contribute to the frequent ligand‐dependent activation of RTK in tumors.

12 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAizea Morales-Kastresana
Aizea Morales-Kastresana
BTBill Telford
Bill Telford
TMThomas A. Musich
Thomas A. Musich
KMKatherine McKinnon
Katherine McKinnon
CCCassandra Clayborne
Cassandra Clayborne
Jennifer JonesJennifer Jones
Jennifer Jones
Extracellular vesicles (EVs), including exosomes and microvesicles, are 30–800 nm vesicles that are released by most cell types, as biological packages for intercellular communication. Their importance in cancer and inflammation makes EVs and their cargo promising biomarkers of disease and cell-free therapeutic agents. Emerging high-resolution cytometric methods have created a pressing need for efficient fluorescent labeling procedures to visualize and detect EVs. Suitable labels must be bright enough for one EV to be detected without the generation of label-associated artifacts. To identify a strategy that robustly labels individual EVs, we used nanoFACS, a high-resolution flow cytometric method that utilizes light scattering and fluorescence parameters along with sample enumeration, to evaluate various labels. Specifically, we compared lipid-, protein-, and RNA-based staining methods and developed a robust EV staining strategy, with the amine-reactive fluorescent label, 5-(and-6)-Carboxyfluorescein Diacetate Succinimidyl Ester, and size exclusion chromatography to remove unconjugated label. By combining nanoFACS measurements of light scattering and fluorescence, we evaluated the sensitivity and specificity of EV labeling assays in a manner that has not been described for other EV detection methods. Efficient characterization of EVs by nanoFACS paves the way towards further study of EVs and their roles in health and disease.

1 December 2009 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
ADAnup Dey
Anup Dey
ANAkira Nishiyama
Akira Nishiyama
TKTatiana S Karpova
Tatiana S Karpova
JMJames McNally
James McNally
KOKeiko Ozato
Keiko Ozato
On entry into mitosis, many transcription factors dissociate from chromatin, resulting in global transcriptional shutdown. During mitosis, some genes are marked to ensure the inheritance of their expression in the next generation of cells. The nature of mitotic gene marking, however, has been obscure. Brd4 is a double bromodomain protein that localizes to chromosomes during mitosis and is implicated in holding mitotic memory. In interphase, Brd4 interacts with P-TEFb and functions as a global transcriptional coactivator. We found that throughout mitosis, Brd4 remained bound to the transcription start sites of many M/G1 genes that are programmed to be expressed at the end of, or immediately after mitosis. In contrast, Brd4 did not bind to genes that are expressed at later phases of cell cycle. Brd4 binding to M/G1 genes increased at telophase, the end phase of mitosis, coinciding with increased acetylation of histone H3 and H4 in these genes. Increased Brd4 binding was accompanied by the recruitment of P-TEFb and de novo M/G1 gene transcription, the events impaired in Brd4 knockdown cells. In sum, Brd4 marks M/G1 genes for transcriptional memory during mitosis, and upon exiting mitosis, this mark acts as a signal for initiating their prompt transcription in daughter cells.

14 January 2003 in Journal of Microscopy
Verified
Journal Article
Closed access
PDF file
TKTatiana S Karpova
Tatiana S Karpova
CBC. T. Baumann
C. T. Baumann
LHL. He
L. He
XWX. Wu
X. Wu
AGA. Grammer
A. Grammer
JMJ. G. McNally
J. G. McNally